HeartBeam (BEAT)
(Delayed Data from NSDQ)
$2.47 USD
+0.22 (9.78%)
Updated Sep 5, 2024 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for HeartBeam, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 15 | 13 | 2 | 1 | 0 |
Income After Depreciation & Amortization | -15 | -13 | -2 | -1 | 0 |
Non-Operating Income | 1 | 0 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 2 | 0 | 0 |
Pretax Income | -15 | -13 | -4 | -1 | -1 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -15 | -13 | -4 | -1 | -1 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -15 | -13 | -4 | -1 | -1 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -15 | -13 | 0 | -1 | 0 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 2 | 0 | 0 |
Income After Depreciation & Amortization | -15 | -13 | -2 | -1 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 20.33 | 8.17 | 4.29 | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.72 | -1.59 | -1.03 | NA | NA |
Diluted Net EPS (GAAP) | -0.72 | -1.59 | -1.03 | -0.29 | NA |
Fiscal Year end for HeartBeam, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 5.09 | 4.79 | 4.11 | 3.73 | 3.31 |
Income After SG&A, R&D, and Dept/Amort Expenses | -5.09 | -4.79 | -4.11 | -3.73 | -3.31 |
Non-Operating Income | 0.13 | 0.18 | 0.23 | 0.27 | 0.16 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -4.96 | -4.61 | -3.88 | -3.47 | -3.15 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -4.96 | -4.61 | -3.88 | -3.47 | -3.15 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -4.96 | -4.61 | -3.88 | -3.47 | -3.15 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 26.57 | 26.51 | 20.33 | 26.45 | 19.69 |
Diluted EPS Before Non-Recurring Items | -0.19 | -0.17 | -0.13 | -0.13 | -0.16 |
Diluted Net EPS (GAAP) | -0.19 | -0.17 | 0.07 | -0.13 | -0.16 |